Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05653635
PHASE2

Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study

Sponsor: Centre Paul Strauss

View on ClinicalTrials.gov

Summary

ReciDOPA is a phase II, single-stage randomized, multicenter, prospective trial assessing the efficacy of an irradiation protocol based on Intensity-modulated radiation therapy with simultaneous-integrated boost guided by FDOPA-PET in patient with recurrent glioblastoma.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

54

Start Date

2026-03-01

Completion Date

2028-09-01

Last Updated

2026-02-04

Healthy Volunteers

No

Conditions

Interventions

RADIATION

Simultaneous-integrated boost with IMRT

Simultaneous-integrated boost guided by FDOPA-PET

Locations (2)

CHRU de Nancy

Nancy, De, France

Centre Paul Strauss

Strasbourg, France